Innoskel

Developer of novel therapeutic solutions for the treatment of skeletal disorders

placeValbonne, Provence Alpes Cote D Azur, France calendar_todayFounded 2020 groups27 employees language innoskel.com

Innovation

3 patent families — focus: Chemistry & metallurgy; filing pace steady. Cited 265 times.

YearFilings
20233
20253

Investor mix

4 investors on record; lead investors include Vida Ventures, Jeito.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon